Author: Alan Brochstein, CFA
In Episode 57, host Brandon David of Investing in Cannabis interviewed Chris Schroeder of Somatik, which offers a cold brew medical cannabis coffee infused with 15mg of THC. Schroeder, who...
Well-known cannabis investor Alain Bankier recently participated in the ‘Thought Leaders In Cannabis’ Series, co-hosted by PotBotics & Greenhouse Ventures. Bankier, who has been involved with New York Angels...
In yet another example of publicly-traded Canadian companies entering the U.S. cannabis industry, Canadian Bioceuticals (CSE: BCC) (OTC: CBICF), through its CGX Life Sciences subsidiary, announced today the acquisition...
CNBC reporter Jane Wells interviewed Joel Schneider, CEO of The MaryJane Group (OTC: MJMJ) yesterday in a discussion that highlighted some of the many challenges cannabis entrepreneurs face. His company...
A week ago, cannabis software company MJ Freeway suffered an attack that took it offline, as first reported by Chris Walsh of Marijuana Business Daily. A week later, the...
Following up on its September initiation of coverage of the cannabis industry, Cowen and Company has extended its coverage to Canada in a report entitled “O Cannabis! – Initiating...
Cannabis stocks are hot, with trading volumes remaining strong into 2017 after a 88% rise in the Cannabis Stock Index last year, with all of the gains coming after...
Investment Bank Cowen and Company, which initiated coverage on the cannabis industry in September, is hosting a gathering of institutional investors in New York City on January 12th. Several...
Just one year after announcing an alliance with New Frontier, Arcview Market Research revealed that it will now be working with BDS Analytics to create its 5th Edition of The State...
Building a cannabis empire in the United States is no easy task given the many obstacles created by federal illegality of the plant. Access to banking, an inability to scale operations...
Early trading in CanniMed Therapeutics (TSX: CMED) was disappointing, as the recent IPO broke its $12 offering price and traded below the $11.28 underwriters price. In the first half-hour...
Perhaps the biggest story of 2016 in the cannabis capital markets was the surge in prices and the amount of capital raised for the cannabis industry in Canada during...
Canabo Medical (TSXV: CMM) (OTC: CAMDF) announced that it has closed its $8.4 financing with Aphria (TSXV: APH) (OTC: APHQF), selling the licensed producer 6mm shares at $1.40 in...
As Canadian licensed producers have prepared to add capacity in conjunction with the transition ahead from a medical cannabis program solely to a broader legalized cannabis environment likely to...
CanniMed Therapeutics (TSX: CMED) priced its initial public offering at $12, selling 5mm shares through a syndicate led by AltaCorp Capital to raise $60mm. The underwriters, which also included Canaccord...
With little fanfare, the world’s first cannabis mutual fund launched earlier this year, and it has failed miserably to date, with investors actually losing money during a major bull...
Canada’s Task Force on Cannabis Legalization and Regulation published its long-awaited report today. The report, delivered to Jody Wilson-Raybould, Minister of Justice and Attorney General of Canada, Jane Philpott,...
Atlanta-based Surterra Holdings filed a Form D with the SEC on December 9th indicating it had raised $10.3mm from the sale of equity to 3 investors, with the first sale...
Canopy Growth (TSX: CGC) (OTC: TWMJF) announced the largest equity raise to date for the Canadian cannabis sector, raising over $60mm in a bought deal led by GMP Securities...
Innovative Industrial Properties (NYSE: IIPR) priced its IPO this week, a deal that marks a significant milestone for the cannabis industry but that was a major disappointment for the...
Scotts Miracle-Gro (NYSE: SMG) followed up on previous disclosures regarding its investment in AeroGrow International (OTC: AERO), taking control of the Boulder-based company by exercising warrants it held and...
The list of Canadian licensed producers (LPs) of cannabis expecting to go public just got longer. CanniMed Therapeutics, the parent of CanniMed Ltd. and Prairie Plant Systems, issued a press...
The Innovative Industrial Properties IPO, originally planned at $175mm, has been reduced to $100mm, according to the 4th amendment to the S-11 registration statement. The offering, which was originally...
The pending IPO of Innovative Industrial Properties (NYSE: IIPR), originally expected to price earlier this week, was delayed until at least next week. The company filed a third amendment...
One of the biggest stories in the cannabis industry this year has been the massive amount of capital raised by licensed producers in Canada. Already OrganiGram (TSXV: OGI) (OTC:...
